Navigation Links
Lilly Reports Solid Second-Quarter Results
Date:7/24/2008

hg.

------------------------- -------------------------

Net sales $5,150.4 $4,631.0 11% $9,958.0 $8,929.8 12%

Cost of sales 1,200.9 998.9 20% 2,312.2 1,937.3 19%

Research and

development 951.5 854.4 11% 1,828.6 1,700.6 8%

Marketing, selling

and administrative 1,700.1 1,524.7 12% 3,250.6 2,897.4 12%

Acquired in-process

research and

development 35.0 328.1 NM 122.0 656.6 NM

Asset impairments,

restructuring and

other special

charges 88.9 - NM 234.6 123.0 NM

------- ------- ------- -------

Operating income 1,174.0 924.9 NM 2,210.0 1,614.9 NM

Net interest

income (expense) 4.7 (8.7) 1.2 (17.2)

Joint-venture

income - - - -

Net other income 27.6 10.5 51.4 35.8

------- ------- ------- -------

Other income 32.3 1.8 52.6 18.6

Income before

income taxes 1,206.3 926.7 30% 2,262.6 1,633.5 39%

Income taxes 247.5 263.1 (6)% 239.5 472.7 (49)%

------- ------- ------- -------

Net income $958.8 $663.6 44% $2,023.1 $1,160.8 74%

======= ======= ======= =======

Earnings per share

- basic $0.88 $0.61 44% $1.85 $1.07 73%

======= ======= ======= =======

Earnings per share

- diluted $0.88 $0.61 44% $1.85 $1.07
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. Lilly to Acquire SGX Pharmaceuticals
2. Lillys Connelly Appointed to the Presidents Commission on White House Fellowships
3. Lilly Employees from Nearly 50 Nations Participate in Companys First-Ever Global Day of Service
4. Lilly Backs Federal Legislation to Inform the Public on Payments to Physicians
5. Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex
6. Lilly CEO Urges Policy Prescriptions to Help Ensure Public and Private Biotech Investments Generate Dividends and U.S. Job Growth
7. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
8. Lilly Reports Solid First-Quarter Results
9. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
10. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
11. Lilly Announces Termination of AIR Insulin Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2015)... Calif. , May 20, 2015 ... today presented preliminary data demonstrating the ability of ... pulmonary fibrosis (IPF) from other interstitial lung diseases ... suggest the classifier,s potential to help thousands of ... resolve ambiguity in IPF diagnosis – a frequent ...
(Date:5/20/2015)... 2015 The global genotyping market is ... the forecast period of 2015 to 2020 to reach ... in drug discovery and development process and to provide ... addition to this,heavy investments by key manufacturers to offer ... propelling market growth. Browse 113 market data tables & ...
(Date:5/20/2015)... , May 20, 2015  Cypher Genomics, ... a collaboration with Celgene Corporation to apply Cypher,s ... biomarkers that associate with patient response to innovative ... intended to help accelerate patient access to the ... in clinical research and development and potentially inform ...
(Date:5/20/2015)... 20, 2015 The Greater Gift ... organization, is pleased to announce they are donating 10,010 ... These donations represent the effort and commitment of clinical ... GGI partner sites in 2014. , With a ... good of clinical trial participation, GGI supports International Clinical ...
Breaking Biology Technology:Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 2Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 3Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 4Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 5Cypher Genomics Collaborates with Celgene Corporation to Identify Novel Genomic Biomarkers 2The Greater Gift Initiative Donates over 10,000 Vaccines in Honor of International Clinical Trials Day 2
... Professor of Physics Dr. Satyendra Kumar recently was ... its Directors Award for Excellence for recognition of ... condensed matter physics proposals. In all, seven program ... in Arlington, Va. , The NSF Directors ...
... Data Demonstrated Improved Progression-free Survival with Campath, ... Corp. (Nasdaq: GENZ ) and Bayer HealthCare ... the U.S. Food and Drug Administration,(FDA) has approved ... and granted regular approval for single-agent,Campath for the ...
... (Nasdaq: CADX ), a biopharmaceutical company focused ... use in the hospital setting, announced today that ... the corporate overview on,Thursday, September 27, 2007 at ... the UBS 2007 Global Life Sciences Conference in ...
Cached Biology Technology:FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 2FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 3FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 4FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 5FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 6Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at UBS 2007 Global Life Sciences Conference 2
(Date:5/19/2015)... NEW YORK , May 19, 2015  Technology ... resources both internally and in the cloud. Passwords and ... the use of OTP and standards-based specifications such as ... that the outmoded use of passwords presents for BYOD, ... needs a unified biometric identity protocol. ...
(Date:5/11/2015)... SAN JOSE, Calif. , May 11, 2015 ... leading developer of human interface solutions, today announced ... Senior Vice President and Chief Financial Officer, reporting ... Mr. Ali replaces Synaptics, current Chief Financial Officer, ... in December 2014. Mr. Ali ...
(Date:5/7/2015)... , May 7, 2015 ... sensors, FPC1022 and FPC1035, FPC,s smallest touch fingerprint ... are mainly considered for integration on the backside ... smartphone OEMs increased possibilities to integrate touch fingerprint ... size also improves possibilities for module manufacturers to ...
Breaking Biology News(10 mins):HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2
... 22, 2013 More accurate and precise assessment of ... a particular gene that are present in a genome, ... cancer and other diseases including autoimmune disorders. However, ... labor intensive, or prohibitively costly, diminishing their effectiveness in ...
... soil and leaks out as nitrate for decades towards groundwater ... at the University of Calgary say in a new study. ... applied to crops in 1982, about 15 per cent of ... scientists found. After three decades, approximately 10 per cent ...
... It has long been known that the characteristics of many ... in climate. But changes in grazing pressure and pollination can ... to a new study. Researchers at Uppsala University and ... the journal Proceedings of the National Academy of Sciences ...
Cached Biology News:Bio-Rad's Droplet Digital PCR technology highlighted at ASHG Annual Meeting 2Nitrogen fertilizer remains in soils and leaks towards groundwater for decades, researchers find 2Nitrogen fertilizer remains in soils and leaks towards groundwater for decades, researchers find 3Grazers and pollinators shape plant evolution 2
...
Recombinant Rat Leptin, CF...
Adhesive seal-tab, for HybriWell™ hybridization sealing system *set of 400*...
... The CultureWell cell culture systems provide ... cells for staining and imaging. Each ... with standard optical-quality coverslips in cell ... provided sterile and ready to use. ...
Biology Products: